🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Leah H. Biller

Harvard University

ORCID: 0000-0001-7386-7121

Also affiliated with Dana-Farber Cancer Institute, Cancer Genetics (United States)

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study”.

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00522-2
N/A
3.0DataRank · unranked
96 citations

Elizabeth Page, Mark N. Brook, Sarah Thomas, Natalie Taylor, Jennifer Pope +95 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073
N/A
0.840DataRank · unranked
30 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

Nature Communications(2023)10.1038/s41467-023-40024-3
N/A
0.635DataRank · unranked
68 citations

Michael H. Rosenthal, Tilak Sundaresan, Natalia Khalaf, Valerie Lee, Lauren K. Brais +20 more

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2005
N/A
0.503DataRank · unranked
14 citations

Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal +23 more

Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome

Gastroenterology(2021)10.1053/j.gastro.2021.03.039
N/A
0.449DataRank · unranked
19 citations

Miki Horiguchi, Hajime Uno, Chinedu Ukaegbu, Sapna Syngal, Matthew B. Yurgelun +1 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092
N/A
0.208DataRank · unranked
3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more

Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.

Familial Cancer(2020)10.1007/s10689-020-00199-w
N/A
0.104DataRank · unranked
1 citations

Sapna Syngal, Matthew B. Yurgelun, Leah H. Biller

The “scope” of colorectal cancer screening in Lynch syndrome: is there an optimal interval?

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad074
N/A
0DataRank · unranked
5 citations

Kimmie Ng, Leah H. Biller

Inherited Pancreatic Cancer Syndromes and High-Risk Screening

Surgical Oncology Clinics of North America(2021)10.1016/j.soc.2021.06.002
N/A
0DataRank · unranked
17 citations

Brian M. Wolpin, Michael Goggins, Leah H. Biller

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436
N/A
0DataRank · unranked
13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more